Navigation Links
Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
Date:4/14/2008

Executive Leadership Changes Further Position Company to Meet Strategic

Growth Objectives

CINCINNATI, April 14 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the promotion of Simon S. Higginbotham to the role of President. Chris Bergen, who previously had served as President and Chief Operating Officer, will continue as Chief Operating Officer. In his new role as President, Mr. Higginbotham will provide global leadership for worldwide customer and business expansion to include strategic customer relations and new market opportunities. Assuming the position of Vice President and Chief Marketing Officer held previously by Mr. Higginbotham is Alan J. Boyce, who brings extensive senior-level sales and marketing experience in the biopharmaceutical industry to Kendle. Mr. Boyce was Vice President, Global Clinical Development -- Europe and Africa for Kendle from 2003 to 2007. In his new role with Kendle he will provide global leadership for the company's new business development and marketing initiatives. Combined, these executive leadership changes further realign Kendle with its long-term growth strategy and position the company to deliver improved value to its customers and shareholders.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"As we embark on the next stage of our corporate growth, it is imperative we have the dedicated leadership strength in place to support our needs as a larger global organization," said Candace Kendle, PharmD, Chairman and Chief Executive Officer. "Simon Higginbotham is a proven leader wit
'/>"/>

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
2. Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
3. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
4. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
5. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
6. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
7. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
8. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
9. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
10. Vitasoy Promotes the Soy Breast Health Connection
11. AvMed Promotes Kirk Cianciolo to Senior Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... Conn., July 24 /PRNewswire/ -- People think it,s ...ffer many opportunities to eat right,and stay fit....t menu,selections, so if you order carefully your ...o: http://www.newscom.com/cgi-bin/prnh/20071212/N...mptation, you,ll want to stay,away from the cruise...
(Date:7/24/2008)... Greater access for people with disab...oad on ,Social Security disability system. , ...24, 2008 -- With the signing of the Americans with...n in the lives of people with disabilities and the... gained better access to methods that help them im...
(Date:7/24/2008)... A cleanroom manufacturing company ha...cleanrooms. The feature is a utility panel which ...hance the cleanroom appearance. , ...- Gerbig Engineering, a designer, fabricator and i...t they are now offering a utility panel for integr...
(Date:7/24/2008)... As America's baby boomers age, ...itions such as diabetes that necessitate the use o...t bracelet jewelry gives a generation attractive i...mation. , (PRWEB) July 24...tening health conditions can make a statement in m...
Breaking Medicine News(10 mins):Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 3Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 2Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 3Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 3
...risk of heart disease through causing inflammation...gum infection may set the scene for heart disease.... the heart - C - reactive protein (CRP). Researche...hat people with gum disease have higher than norma...
...ess is being collected on a database which both do...gredient in medical research is the patient's voic...s, but doctors and researchers could learn a lot f...ut their illness. It would help new patients too -...
...ancreas can benefit from 'keyhole' surgery, accord...surgery is increasing in popularity for a number o...ar and less time in hospital after the operation. ...ough which miniature instruments are inserted. The...
...isease also improves the paralysis experienced by ...transmitter dopamine in the body, and this may hel...function more normally. It's used as a treatment i... that levodopa is also helpful in alleviating stro...
Other Medicine News:
(Date:7/23/2008)... BOSTON, July 23 /- FluoroPharma ...imaging agents for the Positron Emission Tomograph... for BFPET, its novel,Fluorine-18 labeled tracer f...arma,s second cardiovascular product to complete P...ing agent, designed to assess the blood flow in th...
(Date:7/23/2008)... Company Focused on IND-Enabling Work with Pro...ive Pathway of Complement System, CAMBRIDGE, Mass...c.,today announced it has initiated a corporate gr...Ph.D., as chief executive officer and the,establis...Celniker succeeds,Woodruff Emlen, M.D., a co-found...
(Date:7/22/2008)... Latest awards under Therapeutics Development ...llaborations to 23; next deadline January 20,2009... part of its mission to,speed delivery of transfor...se, The Michael J. Fox Foundation for Parkinson,s ... to six industry research teams. The awards,were g...
(Date:7/22/2008)... Two Regimens Including Lantus(R) and Apidra(R)...ients with Type 2 Diabetes, Whatever the Algorithm...ER, N.J., July 22 /- Results from the...of a Simple Algorithm to Carbohydrate,Counting for...were,published in the American Diabetes Associatio...
Breaking Medicine Technology:FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Front Line Caregiver Coalition Thanks Sens Conrad Coleman and Reps Pomeroy Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Admi 21200 1Front Line Caregiver Coalition Thanks Sens Conrad Coleman and Reps Pomeroy Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Admi 21200 2Cline Davis 26 Mann Launches Platform Advisors 28TM 29 a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pha 21197 1Cline Davis 26 Mann Launches Platform Advisors 28TM 29 a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pha 21197 2Niacins role in maintaining good cholesterol 3545 1Duke chemist has new way to tell right from left 21192 1Duke chemist has new way to tell right from left 21192 2
For the direct, colorimetric determination of calcium in human serum or urine. Linearity: 20 mg/dl.
Alanine Aminotransferase (ALT) reagent is used for the quantitative determination of alanine aminotransferase (Glutamate pyruvate transaminase, SGPT) in human serum.
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution.
For the determination of urea nitrogen in human serum.
Medicine Products: